How much is your health worth? A research agenda on valuation processes and markets for medicines

Etienne Nouguez

economic sociology. perspectives and conversations, 2020, vol. 21, issue 3, 11-19

Abstract: The stakes around the global and national medicines markets have been rising steadily for the last twenty years. From the controversies over patents surrounding HIV treatments and the right of developing countries to infringe these patents and develop generic copies in the late 1990s ('t Hoen 2002; Coriat 2008), to the current debates over the exorbitant prices of certain medicines and the sustainability of the expenditure they generate for national health insurance (Vogler et al. 2016), or, in the current context of the Covid-19 pandemic, over supply disruptions and struggles between countries to access treatments, tests, and protective masks - medicines and health products raise a series of fundamental questions.

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/223121/1/Econsoc-NL-21-3-02.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:econso:223121

Access Statistics for this article

economic sociology. perspectives and conversations is currently edited by Sascha Münnich

More articles in economic sociology. perspectives and conversations from Max Planck Institute for the Study of Societies Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().